Information, Pharmaceuticals and Psychedelic therapy

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Information

Pharmaceuticals

Psychedelic therapy

One Person’s Journey from Celebrity Medical Model Advocate to Skeptic: An Interview with Rose Cartwright

Mad in America

NOVEMBER 6, 2024

But things shifted — you write that you were confronted with information and experiences that challenged this understanding. You write that you worry about how psychedelics are getting co-opted by pharmaceutical industries. It was then turned into TV show. Dhar: That was my favorite part, the gentleness. Tell us more.

Trauma and the brain

Trauma and the brain Poverty and mental health Psychedelic therapy Childhood trauma

A Win for Science, with Profound Implications for Industry: FDA Rejects MDMA

Mad in America

AUGUST 14, 2024

The retraction notice takes strong language: “The Editors have retracted this article after they were informed of protocol violations amounting to unethical conduct at the MP4 study site by researchers associated with this project. And since SSRIs are prescribed for PTSD, this would be a treatment competing with pharmaceutical giants.

Pharmaceuticals

Pharmaceuticals Nonprofits Psychedelic therapy

Mental Health Clinicians

One Person’s Journey from Celebrity Medical Model Advocate to Skeptic: An Interview with Rose Cartwright

A Win for Science, with Profound Implications for Industry: FDA Rejects MDMA

Stay Connected